TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT05311800

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Physical activity
Description: Comparison of HIIT mode (running vs cycling)

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Physical activity
Description: Comparison of HIIT mode (running vs cycling)
Study: NCT05120089

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: muscle energy technique and myofacial release (physiotherapy techniques)
Description: Each technique will be applied for three month (3 session/week)

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: muscle energy technique and myofacial release (physiotherapy techniques)
Description: Each technique will be applied for three month (3 session/week)
Study: NCT04791280

Intervention type: PROCEDURE
Intervention: Faeces collection
Description: * faeces collection at inclusion~* follow-up visit 6 months after inclusion
Study: NCT04866615

Intervention type: DIAGNOSTIC_TEST
Intervention: Optvue OCT
Description: Optical coherence tomography

Intervention type: DIAGNOSTIC_TEST
Intervention: Optvue OCT
Description: Optical coherence tomography

Intervention type: DIAGNOSTIC_TEST
Intervention: Optvue OCT
Description: Optical coherence tomography
Study: NCT05602649

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cannabis
Description: Cannabis will be orally ingested

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cannabis
Description: Cannabis will be orally ingested

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cannabis
Description: Cannabis will be orally ingested

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cannabis
Description: Cannabis will be orally ingested

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cannabis
Description: Cannabis will be orally ingested

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cannabis
Description: Cannabis will be orally ingested

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo will be orally ingested

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo will be orally ingested

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo will be orally ingested
Study: NCT06108375

Intervention type: OTHER
Group type: OTHER
Intervention: music therapy
Description: music played live by a music therapist

Intervention type: OTHER
Group type: OTHER
Intervention: music therapy
Description: music played live by a music therapist

Intervention type: OTHER
Group type: OTHER
Intervention: recording
Description: a recording of the same music played by the music therapist

Intervention type: OTHER
Group type: OTHER
Intervention: recording
Description: a recording of the same music played by the music therapist
Study: NCT06579976

Intervention type: OTHER
Intervention: No intervention
Description: This is an observational study, no intervention will be implemented.

Intervention type: OTHER
Intervention: No intervention
Description: This is an observational study, no intervention will be implemented.
Study: NCT05019664

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Affixus Natural Nail System
Description: Intramedullary nailing designed for fixation and stabilization of fractures or osteotomies of the humerus. Nails are comprised of proximal and antegrade/retrograde.
Study: NCT06578884

Intervention type: DEVICE
Intervention: 877PTY
Description: IOL implantation with 6-month follow-up period Monocular UDVA/CDVA Manifest Refraction (SPH, CYL, SEQ) Optical Biometry, Keratometry (K1, K2, AXL, ACD) IOL axis orientation determination Visual function questionnaire Glistening evaluation Tonometry Slit-Lamp examination Fundus visualization
Study: NCT05995028

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Universal CD7-specific CAR gene-engineered T cells
Description: Infusion of 4SCAR7U T cells
Study: NCT05864079

Intervention type: DIAGNOSTIC_TEST
Intervention: Developmental endothelial locus-1 (DEL-1)
Description: Serum DEL-1 in study groups

Intervention type: DIAGNOSTIC_TEST
Intervention: Developmental endothelial locus-1 (DEL-1)
Description: Serum DEL-1 in study groups

Intervention type: DIAGNOSTIC_TEST
Intervention: Developmental endothelial locus-1 (DEL-1)
Description: Serum DEL-1 in study groups

Intervention type: DIAGNOSTIC_TEST
Intervention: soluble P-selectin (sP-sel)
Description: Serum sP-sel in study groups

Intervention type: DIAGNOSTIC_TEST
Intervention: soluble P-selectin (sP-sel)
Description: Serum sP-sel in study groups

Intervention type: DIAGNOSTIC_TEST
Intervention: soluble P-selectin (sP-sel)
Description: Serum sP-sel in study groups
Study: NCT05356195

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: CTX001
Description: Administered by intravenous infusion following myeloablative conditioning with busulfan.
Study: NCT05830994

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: G-POEM
Description: An Endoscopic submucosal tunnel is formed and extended to the first part of the duodenum, followed by a pyloromyotomy, beginning approximately two centimetres proximal to the pylorus and ending in the first part of duodenum.

Intervention type: PROCEDURE
Group type: PLACEBO_COMPARATOR
Intervention: Sham
Description: Endoscopy is performed and tissue samples are collected from fundus and antrum as part of the Sham procedure
Study: NCT05433532

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Azacitidine
Description: Azacitidine: 75mg/m2 qd, d1-d7, subcutaneous injection

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Venetoclax
Description: Venetoclax: 100mg d1, 200mg d2, 300mg d3, 400mg d4-d14 or 21, oral (Adjusted according to the peripheral blood BCR/ABL1 results on day 14)

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Flumatinib
Description: Flumatinib: 600mg qd, d4-d21, oral
Study: NCT05878002

Intervention type: DEVICE
Group type: OTHER
Intervention: polysomnography
Description: Sleep study through polysomnographic examination
Study: NCT06476912

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: weight-shifting exercise
Description: lateral weight-shifting balance training and VNS
Study: NCT05827952

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: behavior modification-Atomic Habit by hybrid
Description: Atomic Habits (20-minute audiobook format), a role structure, and a game structure, online schedule reminders more than twice a week, and individual counseling sessions (online and physical) with one to two total interventions. The content of the online schedule reminders consisted of a total of four concepts for each of the four major habits, and a total of 16 sessions of the online audiobook interventions were adapted for the caregivers' relationship-building habits with the children.
Study: NCT04235335

Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Indigenous Mother's Empowerment Program & Indigenous Kid's Club Program
Description: Weekly groups administered to mothers and children simultaneously but separately for 10 weeks
Study: NCT05018884

Intervention type: PROCEDURE
Intervention: Observation of surgical site infections
Description: No intervention is done, only observation of routine clinical practice
Study: NCT05282043

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Evaluation of Pulmonary and Extrapulmonary Impacts of COVID-19 on Young Adults
Description: Participants' upper extremity and lower extremity muscle strength, 6-minute walking distance, O2 saturation, posture evaluation, spirometric evaluation, pain threshold, pain intensity, dyspnea, and leg fatigue measurements will be recorded. In addition to these measurements, general fatigue, quality of life, depression, physical activity level, sleep quality parameters will be evaluated and the data obtained will be analyzed with appropriate statistical methods.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Evaluation of Pulmonary and Extrapulmonary Impacts of COVID-19 on Young Adults
Description: Participants' upper extremity and lower extremity muscle strength, 6-minute walking distance, O2 saturation, posture evaluation, spirometric evaluation, pain threshold, pain intensity, dyspnea, and leg fatigue measurements will be recorded. In addition to these measurements, general fatigue, quality of life, depression, physical activity level, sleep quality parameters will be evaluated and the data obtained will be analyzed with appropriate statistical methods.
Study: NCT06476912

Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: weight-shifting exercise
Description: lateral weight-shifting balance training and VNS
Study: NCT05374902

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Providing procedural informational animation video
Description: Children and parents have watched procedural informational animation before venipuncture. Afterward, the children and their parents entered the blood drawn unit, and the procedure was performed as in standard care.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Buzzy
Description: Buzzy® was placed on the injection site and it was turned on 60 s before the procedure. Then, the nurse moved Buzzy® about 3-5 cm above the injection site. The procedure was performed with buzzy®. The Buzzy® intervention and phlebotomy were terminated at the same time.

Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: Multiple interventions
Description: Watching procedural informational animation video prior to venipuncture, and Buzzy application during venipuncture
Study: NCT05903625

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Control Group - Standard White Bread
Description: Participants consume commercially available standard white bread, serving as the control intervention.

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Lysine Group - Lysine-Fortified Bread
Description: Participants consume bread fortified with lysine, an essential amino acid, in a specified dosage, frequency, and duration.

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Phosphorus Group - Phosphorus-Fortified Bread
Description: Participants consume bread fortified with phosphorus, an essential mineral, in a specified dosage, frequency, and duration

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Lysine and Phosphorus Group - Double Fortified Bread
Description: Double Fortified Bread: Participants consume bread fortified with both lysine and phosphorus in specified dosages, frequencies, and durations.
Study: NCT06589245

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Alvesco Inhalant Product
Description: Inhaled Alvesco will be administered daily for 14 days at escalating doses of 80mcg, 160mcg and 320mcg.
Study: NCT06666270

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SYN818
Description: Patients will orally receive SYN818
Study: NCT06315829

Intervention type: DEVICE
Intervention: Spasm Vision
Description: Machine learning software developed to analyze videos and accurately distinguish infantile spasms from visually similar movements.

Intervention type: DEVICE
Intervention: Spasm Vision
Description: Machine learning software developed to analyze videos and accurately distinguish infantile spasms from visually similar movements.

Intervention type: DEVICE
Intervention: Spasm Vision
Description: Machine learning software developed to analyze videos and accurately distinguish infantile spasms from visually similar movements.
Study: NCT06666842

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Noom Weight
Description: Participants assigned to Noom Weight will be provided access to the app-based program for 16 weeks. This program offers access to self-monitoring features, psychoeducational articles, one-on-one coaching from health experts, and group support. The app includes a robust database of foods, allowing users to track their energy intake. Self-monitoring via the app enables users to review and monitor behavior and weight change patterns. Daily articles review principles of behavior change, nutrition, exercise, etc.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Educational Control
Description: Participants assigned to the educational control will receive 16 brief (5-10 minute read) weekly newsletters outlining information on developing and maintaining a healthy diet and lifestyle adapted from the 2015-2020 Department of Health and Human Services (HHS) and Department of Agriculture (USDA) Dietary Guidelines for Americans. Newsletters include detailed information on topics such as nutrition fundamentals (e.g., calorie limits; healthy eating), food groups and dietary guidelines (e.g., importance of vegetables, fruits, and grains), and tips for habit change (e.g., reducing added sugar and saturated fats). Each week includes prompts for individuals to try new strategies (e.g., make a conscious decision about everything you eat; try to eat at your calorie budget).
Study: NCT06661954

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Bed A - supine
Description: Hercules dream air surface in supine position

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Bed B - supine
Description: Oncare Skinguard surface

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Bed A - head of bed at 30 degrees
Description: Hercules dream air surface with head of bed at 30 degrees

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Bed B - head of bed at 30 degrees
Description: Oncare Skinguard surface with head of bed at 30 degrees
Study: NCT06303557

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Preoperative Erector Spinae Plane Block
Description: Erector spinae plane block will be performed bilaterally, under US guidance, before the surgical operation, after the induction of anesthesia, and when the patient is placed in the prone position.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Postoperative Erector Spinae Plane Block
Description: Erector spinae plane block will be performed unilaterally, under US guidance, after the surgical operation, under general anesthesia, and when the patient is placed in the prone position.
Study: NCT06608563

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Fissure sealant without adhesive system (NO BOND)
Description: 1. Cotton roll isolation~2. Etching of the enamel surface: 17% phosphoric 15 seconds over the surface to be sealed (Phosphoric etchant gel - Vococid, VOCO)~3. Washing/drying: a 3-1 syringe will be used to rinse all etch material from the toothsurface.~4. Sealant application: a light-curing nano-hybrid fissure sealant material (Grandio Seal; VOCO) will be applied using the applicator tip.~5. Lightcuring: The material will be lightcured for 20 seconds.

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Fissure sealant with adhesive system (BOND)
Description: 1. Cotton roll isolation~2. Etching of the enamel surface: 17% phosphoric 15 seconds over the surface to be sealed (Phosphoric etchant gel - Vococid, VOCO)~3. Washing/drying: a 3-1 syringe will be used to rinse all etch material from the toothsurface.~4. Adhesive system application: the adhesive system (Futurabond, VOCO) single dose capsule will be applied over the surface to be sealed for 5 seconds using a microbrush. The adhesive system will be air thin dried and lightcured for 10s before sealant placement.~5. Sealant application: a light-curing nano-hybrid fissure sealant material (Grandio Seal; VOCO) will be applied using the applicator tip.~6. Lightcuring: The material will be lightcured for 20 seconds.
Study: NCT06667778

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Osseodesification densah burs
Description: Drill no. VT1525 (2mm) of densah burs will be used first in counter clockwise (in the osteotomy site).~Then drill no. VT2535 (3mm) of densah burs will be used in counter clockwise to put 3.5mm implant diameter.

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Microdent
Description: No. 1 Microdent expander will be placed and screwed slowely (to avoid heat generation) into the osteotomy site till reaching the full desired length.~N0. 2 microdent expander will be placed and screwed into the osteotomy site as the same step.~Then no. 3 Microdent expander will be inserted for placing 3.5mm implant diameter
Study: NCT06683625

Intervention type: DIAGNOSTIC_TEST
Intervention: 6K Max Effort Erg Test
Description: 6K Max Effort Erg Test, involves participants completing a 6000-meter rowing distance on an ergometer as quickly as possible. This test is designed to measure peak endurance and performance under controlled conditions and will serve as a primary assessment of each athlete's physical output and adaptive capacity.

Intervention type: DIAGNOSTIC_TEST
Intervention: 6K Max Effort Erg Test
Description: 6K Max Effort Erg Test, involves participants completing a 6000-meter rowing distance on an ergometer as quickly as possible. This test is designed to measure peak endurance and performance under controlled conditions and will serve as a primary assessment of each athlete's physical output and adaptive capacity.
Study: NCT06683131

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tafolecimab
Description: 450mg of tafolecimab (150mg each one) was injected subcutaneously before primary PCI and then every month till totally 12 months.
Study: NCT06681948

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Ketogenic diet
Description: Ketogenic diet

Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: placebo
Description: placebo
Study: NCT06685406

Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Thorathic fluid content measurement by cardiometry
Description: Thorathic fluid content measurement by using cardiometry
Study: NCT06682754

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Stress
Description: All participants will perform a baseline test in which they will have to sit in a chair, get up, walk to a table with two bottles, transfer liquid from one bottle to the other, return to the starting chair and sit down again. Subsequently, they will perform an experimental test, where they will repeat the same movements as in the baseline test after a stressful intervention.
Study: NCT06685029

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Clear aligner treatment
Description: Clear aligners are appliances that allow the teeth to be gradually moved to the desired final position, as planned in the computer program, in a way that each aligner will perform a part of the total movement with its use.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Clear aligner treatment
Description: Clear aligners are appliances that allow the teeth to be gradually moved to the desired final position, as planned in the computer program, in a way that each aligner will perform a part of the total movement with its use.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Clear aligner treatment
Description: Clear aligners are appliances that allow the teeth to be gradually moved to the desired final position, as planned in the computer program, in a way that each aligner will perform a part of the total movement with its use.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Fixed Orthodontic Appliance Treatment
Description: Fixed orthodontic treatment is a type of orthodontic treatment performed by applying brackets and wires to the teeth and is considered the gold standard for orthodontic treatments.
Study: NCT06682468

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Population level patient portal based substance involvement screening
Description: Participants 18 years or older, with an active patient portal account, who have attended an HIV care clinic visit in the HIV clinic in the last two years and have not completed the validated National Institute for Drug Abuse (NIDA) Quick Screen V1.0 in the previous year will be eligible for intervention randomization. Those randomized into the intervention group will receive the validated NIDA Quick Screen V1.0 over their patient portal account. Participants randomized to this group can complete the screener over the patient portal without a scheduled appointment with their HIV clinician.

Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Usual Care Substance Use Involvement Screening
Description: Participants randomized to the usual care group will receive the validated NIDA Quick Screen V1.0 during routine in-clinic visits if they attend their scheduled visit. The medical assistant will ask participants to complete the NIDA Quick Screen V1.0. Participants who endorse the use of illegal drugs or prescription drugs for non-medical reasons, tobacco use, or heavy drinking will be referred to SUD treatment.
Study: NCT06682585

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Individualised dietary intervention
Description: * Energy Intake: Caloric needs will be calculated based on the patient's age, weight, and activity level, taking into account the potential impact of corticosteroid therapy on energy expenditure.~* Protein Intake: Protein requirements will be met through a balanced diet, aiming to optimize muscle protein synthesis.~* Calcium and Vitamin D Intake: Adequate intake of these nutrients will be emphasized to support bone health and prevent osteoporosis.~* Fluid Intake: Fluid intake will be monitored to prevent dehydration and constipation.~* Carbohydrate Intake: A low-glycemic index diet will be recommended to manage blood glucose levels and insulin resistance, especially in patients on corticosteroid therapy.~* Sodium Intake: Sodium intake will be restricted to minimize fluid retention and hypertension.
Study: NCT06685003

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Digital Tutorial overview
Description: Self study of a digital tutorial covering an overview of CRAFT designed to be reviewed within 7 weeks and revisited over 6 months.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Digital Tutorial overview
Description: Self study of a digital tutorial covering an overview of CRAFT designed to be reviewed within 7 weeks and revisited over 6 months.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Digital Tutorial overview
Description: Self study of a digital tutorial covering an overview of CRAFT designed to be reviewed within 7 weeks and revisited over 6 months.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Digital Tutorial plus training Materials
Description: Self study of a digital tutorial covering an overview of CRAFT and deeper materials designed to be reviewed within 7 weeks and revisited over 6 months.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Digital Tutorial plus training Materials
Description: Self study of a digital tutorial covering an overview of CRAFT and deeper materials designed to be reviewed within 7 weeks and revisited over 6 months.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Digital Tutorial plus training Materials plus feedback and Coaching
Description: Self study of a digital tutorial covering an overview of CRAFT and deeper materials designed to be reviewed within 7 weeks and revisited over 6 months. Plus group coaching and feedback on audio recordings of CRAFT procedures used in sessions